Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units
CompletedOBSERVATIONAL
Enrollment
704
Participants
Timeline
Start Date
March 10, 2020
Primary Completion Date
April 15, 2020
Study Completion Date
April 15, 2020
Conditions
Covid19
Trial Locations (1)
48073
Beaumont Health System (BHS), Royal Oak
All Listed Sponsors
lead
William Beaumont Hospitals
OTHER
NCT04829552 - Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units | Biotech Hunter | Biotech Hunter